The ol' correlation-aroo... It's likely that people with poorly managed diabetes/obesity would be at higher risk of this condition AND have a higher rate of these prescriptions.
To me I feel like they get the best deal, because the risk of both blindness and other complications from poorly managed diabetes is still much worse than this.
Its the people using this because they don't want to make changes that are within their power but are difficult who are taking on additional risk for no reason other than convenience. That doesn't mean everyone who doesn't have diabetes but still makes up a large portion of the buyers of this drug.
I have type 2 and have been prescribed ozempic. My numbers are suddenly good and I can feel satiated. Now when people hear that you have type 2 they get an image. I've never been that, but type 2 found me anyhow. Weight-loss is nice, but not as important to me.
My wife ended up on Wegovy. She didn't eat much, walked regularly, went to regular swimming sessions... Did all those things you're supposed to do. Not only did she not lose, she slowly gained. She did all that because it was the right thing to do.
Wegovy hit the market and she qualified in part and mainly because nothing else worked. She was already not eating much. And the insurance paid because she'd been doing Noom, exercise, etc.
So... She and I get the same active ingredient and both benefit. It makes you feel sick for a day or two a week. Certain foods become revolting.
It does what we need. But the stereotypes that people have around these meds aren't entirely accurate.
Which, of course, explains why all blind people are thin. And opens a whole new avenue for weight control. We'll make kitchen light switches that only work within certain BMI ranges. /s
